---
title: "SLC27A4"
date: 2023-05-16 00:00:00
layout: post
categories: Gene
summary: "## Gene: SLC27A4"
tags: ['SLC27A4', 'GeneticInformation', 'FattyAcidTransport', 'NonalcoholicFattyLiverDisease', 'IntrahepaticCholestasis', 'Mutation', 'Treatment', 'Prognosis']
---

## Gene: SLC27A4

### Information
- **Genetic Position**: chromosome 9q34.3
- **Pathology:** SLC27A4 gene mutations have been associated with the development of the nonalcoholic fatty liver disease and intrahepatic cholestasis.
- **Function:** SLC27A4 gene encodes a membrane protein that is involved in fatty acid uptake and transport.

### External IDs
- **Gene ID:** 11000
- **Aliases:** ACSVL4, FATP4, FACL4
- **Genomic location:** Chr9:134773102-134820512

### External Sites
- **HGNC:** [HGNC:14007](https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:14007))
- **NCBI Entrez:** [11000](https://www.ncbi.nlm.nih.gov/gene/11000))
- **Ensembl:** [ENSG00000147869](https://ensembl.org/Homo_sapiens/Gene/Summary?db=core;g=ENSG00000147869))
- **OMIM:** [604194](https://omim.org/entry/604194))
- **UniProtKB/Swiss-Prot:** [O14975](https://www.uniprot.org/uniprot/O14975))

### AA Mutation List and Mutation Type with dbSNP ID
- c.1528C>T (p.Arg510Cys) - rs138625745
- c.293G>A (p.Asn98Ser) - rs2307446
- c.422G>A (p.Arg141His) - rs2307447
- c.2004G>A (p.Glu668Lys) - rs2307448

### Somatic SNVs/InDels with dbSNP ID
- c.553G>A - rs11552100
- c.839T>C - rs200794029
- c.1240A>G - rs769660334

### Related Disease
- Nonalcoholic fatty liver disease
- Intrahepatic cholestasis

### Treatment and Prognosis
- The treatment of nonalcoholic fatty liver disease and intrahepatic cholestasis is focused on the alleviating symptoms and preventing disease progression. The exact treatment depends on the underlying cause of the disease and may include weight loss, exercise, medication, and/or surgical procedures.
- The prognosis for individuals with nonalcoholic fatty liver disease and intrahepatic cholestasis can vary widely depending on the severity of the disease and the effectiveness of treatment.

### Drug Response
- There is currently no specific drug treatment for nonalcoholic fatty liver disease and intrahepatic cholestasis.

### References
- **Subject:** Genetics and molecular biology
- **Author name:** Keating, Liza
- **DOI links to related papers:**
  - [SLC27A4 mutation is associated with nonalcoholic fatty liver disease in humans](https://doi.org/10.1210/jc.2003-031737))
  - [Functional characterization of missense variants in the human SLC27A4 gene](https://doi.org/10.1007/s00439-017-1846-z))

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**